Bimatoprost eye drops are used to reduce high pressure in the eye. This medicine may be used on its own or with other drops called beta-blockers which also reduce pressure.
This report contains market size and forecasts of Bimatoprost Eye Drop in global, including the following market information:
Global Bimatoprost Eye Drop Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bimatoprost Eye Drop Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bimatoprost Eye Drop companies in 2021 (%)
The global Bimatoprost Eye Drop market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.1 mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bimatoprost Eye Drop include Aspire Pharma Ltd, Mylan, Sandoz Limited, AbbVie Ltd and Accord-UK Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bimatoprost Eye Drop manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bimatoprost Eye Drop Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bimatoprost Eye Drop Market Segment Percentages, by Type, 2021 (%)
0.1 mg/ml
0.3 mg/ml
Global Bimatoprost Eye Drop Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bimatoprost Eye Drop Market Segment Percentages, by Application, 2021 (%)
Hospital
Ophthalmic Clinic
Pharmacy
Others
Global Bimatoprost Eye Drop Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bimatoprost Eye Drop Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bimatoprost Eye Drop revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bimatoprost Eye Drop revenues share in global market, 2021 (%)
Key companies Bimatoprost Eye Drop sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bimatoprost Eye Drop sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aspire Pharma Ltd
Mylan
Sandoz Limited
AbbVie Ltd
Accord-UK Ltd